Generics drive Dr Reddy's Q2 revenues up 14%
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories has reported a 14% increase in consolidated revenues to Rs18.4 billion ($382 million) for the second quarter ended September 30th, driven by growth in the generics business.